Evidence map›Paper›PMID 42099791›Full record

ArticleFrontiers in cardiovascular medicine2026

Predictive value of ALBI score in assessing prognosis of NSTEMI: a retrospective cohort study.

Xiaoqiang Chen, Xintao Zhou, Chuanglu Zhao, Lishan Chen, Shuyin Wang, Xinwen Min, Jishun Chen, Xiaolei Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaoqiang Chen *Sinopharm Dongfeng General Hospital (Hubei Research Center of Hypertension), Hubei University of Medicine, Shiyan, Hubei, China.
Xintao Zhou *Sinopharm Dongfeng General Hospital (Hubei Research Center of Hypertension), Hubei University of Medicine, Shiyan, Hubei, China.
Chuanglu ZhaoSinopharm Dongfeng General Hospital (Hubei Research Center of Hypertension), Hubei University of Medicine, Shiyan, Hubei, China.
Lishan ChenSinopharm Dongfeng General Hospital (Hubei Research Center of Hypertension), Hubei University of Medicine, Shiyan, Hubei, China.
Shuyin WangSinopharm Dongfeng General Hospital (Hubei Research Center of Hypertension), Hubei University of Medicine, Shiyan, Hubei, China.
Xinwen MinSinopharm Dongfeng General Hospital (Hubei Research Center of Hypertension), Hubei University of Medicine, Shiyan, Hubei, China.
Jishun ChenSinopharm Dongfeng General Hospital (Hubei Research Center of Hypertension), Hubei University of Medicine, Shiyan, Hubei, China.
Xiaolei LiSinopharm Dongfeng General Hospital (Hubei Research Center of Hypertension), Hubei University of Medicine, Shiyan, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aims to evaluate the predictive value of the albumin-bilirubin (ALBI) score for mortality risk in patients with non-ST-segment elevation myocardial infarction (NSTEMI). Methods: A retrospective analysis was conducted on 982 patients with NSTEMI. A multivariate Cox proportional hazards model was established to analyze the predictive value of ALBI for mortality after hospital discharge in NSTEMI patients. Additionally, restricted cubic spline (RCS) plots were used to analyze the relationship between ALBI and post-discharge mortality. Operating characteristic (ROC) curves were generated to assess the predictive accuracy of ALBI, and nomograms were constructed to facilitate clinical application in predicting mortality after hospital discharge in patients with NSTEMI. Results: Among the 982 participants, 62 (6.3%) developed death during the follow-up. In unadjusted Cox regression models, the ALBI index had a hazard ratio (HR) of 5.07 (95% confidence interval CI: 3.13-8.20, Conclusion: ALBI was significantly associated with the risk of out-of-hospital death in NSTEMI patients. The novel nomogram based on ALBI, NT-proBNP, and GRACE scores showed an improvement in predicting mortality.

Indexed as

ALBIGRACEmortalityNSTEMIpredicted value

Identifiers

PMID42099791
PMCPMC13143790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.